ANASTASIADOU, ELENI
 Distribuzione geografica
Continente #
NA - Nord America 1.944
EU - Europa 766
AS - Asia 129
AF - Africa 23
SA - Sud America 14
OC - Oceania 3
Totale 2.879
Nazione #
US - Stati Uniti d'America 1.934
IT - Italia 372
SE - Svezia 136
IN - India 89
AT - Austria 53
IE - Irlanda 46
CN - Cina 36
DE - Germania 23
ES - Italia 22
TG - Togo 21
UA - Ucraina 21
GB - Regno Unito 18
CH - Svizzera 16
FR - Francia 14
AR - Argentina 13
RO - Romania 13
FI - Finlandia 11
CA - Canada 10
GR - Grecia 5
PL - Polonia 5
AU - Australia 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
JP - Giappone 2
NL - Olanda 2
ZA - Sudafrica 2
CL - Cile 1
HR - Croazia 1
IR - Iran 1
RS - Serbia 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 2.879
Città #
Fairfield 468
Rome 172
Chandler 166
Woodbridge 148
Ashburn 145
Houston 115
Seattle 115
Cambridge 91
Wilmington 81
Ann Arbor 59
Princeton 50
Dublin 46
Vienna 46
San Paolo di Civitate 41
Lawrence 37
Dearborn 32
San Diego 30
Boston 26
Plano 26
Millbury 23
Barcelona 22
Lomé 21
Beijing 17
Andover 13
Washington 13
Bremen 11
Gainesville 11
Federal 10
Basel 9
Phoenix 9
Norwalk 8
Redwood City 8
Toronto 7
Fremont 6
Jacksonville 6
Trento 6
Athens 5
Civitavecchia 5
Falls Church 5
London 5
Hefei 4
Southend 4
Altavilla Vicentina 3
Buenos Aires 3
Des Moines 3
Kunming 3
Mentana 3
Naples 3
Paris 3
Sofia 3
Ariccia 2
Boardman 2
Cham 2
Champs-sur-marne 2
Chaoyang 2
Chiswick 2
Fasano 2
Florence 2
Guangzhou 2
Heidelberg 2
Hyderabad 2
Livorno 2
Muizenberg 2
Riva 2
Romainville 2
Swanley 2
Ueuchi 2
Valmontone 2
Alghero 1
Anzio 1
Atlanta 1
Bangkok 1
Bengaluru 1
Berlin 1
Bern 1
Brno 1
Carrollton 1
Castel Maggiore 1
Castelliri 1
Catanzaro 1
Garden City 1
Guidonia 1
Guiyang 1
Henderson 1
Latina 1
Laval 1
Leawood 1
Linden 1
Los Angeles 1
Magenta 1
Mandi 1
Milan 1
Monte Cremasco 1
Montelibretti 1
Monterotondo 1
Nanchang 1
Nanjing 1
New York 1
Nuremberg 1
Ottawa 1
Totale 2.214
Nome #
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study 163
Sex and gender differences in ischemic heart disease. Endocrine vascular disease approach (eva) study design 132
Epstein-Barr virus encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B cell lymphomas 96
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 95
Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells 94
Hydrophilic gold nanoparticles as Anti-PD-L1 antibody carriers. Synthesis and interface properties 94
EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape 93
Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells. 93
Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2 88
Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo 83
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b 78
EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells 76
Epstein-Barr virus: From kisses to cancer, an ingenious immune evader 75
Epstein-Barr virus and plasmacytoid dendritic cells: A possible duet in autoimmunity 73
Characterization of Epstein–Barr virus genotypes in multiple sclerosis through next generation sequencing approaches 71
Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus. 69
null 69
Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells 68
Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression 67
The Nefarious Nexus of Noncoding RNAs in Cancer 67
MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms 66
Abstract A16: Epstein-Barr virus encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B cell lymphomas 65
CS16-6. Plasmacytoid Dendritic Cells are infected by Epstein Barr virus and induces TLR- dependent type I IFN production 64
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc 61
Non-coding RNA networks in cancer 57
Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex 56
Altered expression of candidate genes in Mayer–Rokitansky–Küster–Hauser syndrome may influence vaginal keratinocytes biologya. A focus on Protein Kinase X 55
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine 53
Molecular networks in Network Medicine: Development and applications 53
MicroRNAs in autoimmunity and hematological malignancies 52
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism 52
Malicious exosomes 51
Overexpression of miR-9 in the Nucleus Accumbens Increases Oxycodone Self-Administration 50
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: cellular, molecular and computational evidence 49
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma 48
Differential DNA methylation encodes proliferation and senescence programs in human adipose-derived mesenchymal stem cells 45
Calcineurin gamma catalytic subunit ppp3cc inhibition by mir-200c-3p affects apoptosis in epithelial ovarian cancer 45
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma 45
Immunomodulatory effect of adipose-derived stem cells: the cutting edge of clinical application 42
Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome 40
MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs 40
When viruses cross developmental pathways 40
Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: An immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells. 39
Sex-Dependent Changes in miRNA Expression in the Bed Nucleus of the Stria Terminalis Following Stress 37
Editorial: Targeting developmental pathways in inflammation and disease 35
null 22
MUC1-C regulates PD-L1 expression in acute myeloid leukemia, via downregulation of miRNAs 20
Inhibiting DNA methylation as a strategy to enhance adipose-derived stem cells differentiation. Focus on the role of Akt/mTOR and Wnt/β-catenin pathways on adipogenesis 18
Sex-related factors in cardiovascular complications associated to COVID-19 14
Revisiting the physiological role of androgens in women 11
Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association 10
Simultaneous targeting of multiple oncomiRs with phosphorothioate or PNA-based anti-miRs in lymphoma cell lines 9
null 7
The Inescapable Influence of Noncoding RNAs in Cancer 5
MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs 5
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics 5
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis 4
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo 4
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes 1
The new world of RNA diagnostics and therapeutics 1
Totale 3.120
Categoria #
all - tutte 6.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019280 0 0 4 0 29 1 3 2 4 52 104 81
2019/2020626 63 24 13 37 83 82 93 69 61 41 37 23
2020/2021326 22 23 14 8 24 35 6 22 36 79 25 32
2021/2022792 17 25 54 76 77 23 17 46 52 25 280 100
2022/2023787 103 169 61 73 65 62 19 49 83 10 54 39
2023/2024191 62 68 61 0 0 0 0 0 0 0 0 0
Totale 3.120